| EMA number | EMEA/H/C/000556 |
| ATC code | J07CA10 |
| Authorisation | 17 February 2005 |
| Withdrawn | 28 August 2008 |
| Revision | 2 |
Quintanrix is indicated for primary immunisation of infants (during the first year of life) against diphtheria, tetanus, pertussis, hepatitis B and invasive disease caused by Haemophilus influenzae type b and for booster immunisation of young children during the second year of life.The use of Quintanrix should be determined on the basis of official recommendations.